Question 1

What is the catalog number for Rotavirus VP6 (Rotavirus VP-6, Rotavirus VP-6, VP6) (FITC) discontinued?

Accepted Answer

The catalog number for Rotavirus VP6 (Rotavirus VP-6, Rotavirus VP-6, VP6) (FITC) discontinued is 227143-FITC.

Question 2

What sizes are available for Rotavirus VP6 (Rotavirus VP-6, Rotavirus VP-6, VP6) (FITC) discontinued?

Accepted Answer

Rotavirus VP6 (Rotavirus VP-6, Rotavirus VP-6, VP6) (FITC) discontinued is available in the following size(s): 100 µL.

Question 3

Is Rotavirus VP6 (Rotavirus VP-6, Rotavirus VP-6, VP6) (FITC) discontinued in stock?

Accepted Answer

Rotavirus VP6 (Rotavirus VP-6, Rotavirus VP-6, VP6) (FITC) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

What is the difference between this product and a similar catalogue number?

Accepted Answer

Differences typically involve clone, conjugate, host species, or validated applications. Compare the respective datasheets, or contact us with both catalogue numbers for a direct comparison.

Question 5

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 6

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Rotavirus VP6 (Rotavirus VP-6, Rotavirus VP-6, VP6) (FITC) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Anti-Smad Interacting Protein 1/ZEB2 Antibody Picoband®, PE Conjugate

Anti-Erythropoietin EPO Antibody Picoband®, HRP Conjugate

Human IgD (Immunoglobulin Delta Heavy Chain) (B-Cell Marker) (IgD26), 1mg/mL

TRP1 (Tyrosinase Related Protein 1) (TA99 + TYRP1/807), CF488A conjugate, 0.1mg/mL

BTLA (BTLA/1528), CF568 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2741), CF647 conjugate, 0.1mg/mL